These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Role of transesophageal echocardiography guided cardioversion in patients with atrial fibrillation, previous left atrial thrombus and effective anticoagulation. Saeed M, Rahman A, Afzal A, Agoston I, Jammula P, Birnbaum Y, Ware DL, Uretsky BF, Schwarz ER, Rosanio S. Int J Cardiol; 2006 Nov 18; 113(3):401-5. PubMed ID: 16822564 [Abstract] [Full Text] [Related]
3. Outcomes of Direct Current Cardioversion in Adults With Congenital Heart Disease. Egbe AC, Asirvatham SJ, Connolly HM, Kapa S, Desimone CV, Vaidya VR, Deshmukh AJ, Khan AR, McLeod CJ, Melduni RM, Ammash NM. Am J Cardiol; 2017 May 01; 119(9):1468-1472. PubMed ID: 28262200 [Abstract] [Full Text] [Related]
4. Improved Ventricular Function after TEE-guided Cardioversion of Atrial Arrhythmias in Patients after the Fontan Operation. Poterucha JT, Egbe AC, Johnson JN, Niaz T, Wackel PL, Cannon BC, Eidem BW, Cetta F. Congenit Heart Dis; 2016 Dec 01; 11(6):578-583. PubMed ID: 27030521 [Abstract] [Full Text] [Related]
6. Risks and outcomes of direct current cardioversion in children and young adults with congenital heart disease. Morello ML, Khoury PR, Knilans TK, Veldtman G, Spar DS, Anderson JB, Czosek RJ. Pacing Clin Electrophysiol; 2018 May 01; 41(5):472-479. PubMed ID: 29476621 [Abstract] [Full Text] [Related]
7. Outcome of direct current cardioversion for atrial arrhythmia in adult Fontan patients. Egbe AC, Connolly HM, Niaz T, McLeod CJ. Int J Cardiol; 2016 Apr 01; 208():115-9. PubMed ID: 26849685 [Abstract] [Full Text] [Related]
9. Safety of short-term use of dabigatran or rivaroxaban for direct-current cardioversion in patients with atrial fibrillation and atrial flutter. Yadlapati A, Groh C, Passman R. Am J Cardiol; 2014 Apr 15; 113(8):1362-3. PubMed ID: 24576547 [Abstract] [Full Text] [Related]